Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
OTCMKTS · Delayed Price · Currency is USD
1.090
0.00 (0.00%)
At close: Jul 21, 2025
United States Steel Market Cap
Genomma Lab Internacional has a market cap or net worth of $1.10 billion as of August 1, 2025. Its market cap has increased by 15.65% in one year.
Market Cap
1.10B
Enterprise Value
1.35B
Revenue
999.08M
Ranking
n/a
PE Ratio
10.68
Stock Price
$1.09
Market Cap Chart
Since June 23, 2008, Genomma Lab Internacional's market cap has increased from 435.89M to 1.10B, an increase of 152.11%. That is a compound annual growth rate of 5.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.10B | -1.48% |
| Dec 31, 2024 | 1.12B | 43.29% |
| Dec 29, 2023 | 778.50M | -9.87% |
| Dec 30, 2022 | 863.79M | -18.07% |
| Dec 31, 2021 | 1.05B | 10.06% |
| Dec 31, 2020 | 957.93M | -4.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |